See also this year's filing and all EDGAR filings for this company.
PDF Report 0001365216_2015_Sucampo_Pharmaceuticals_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001365216, Sucampo Pharmaceuticals Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 122,324,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 151,000 |
| 2 | PropertyPlantAndEquipmentNet | 763,000 |
| 3 | remainder_Assets | 18,336,000 |
| 4 | LiabilitiesCurrent | 33,810,000 |
| 5 | LiabilitiesNoncurrent | 1,936,000 |
| 6 | remainder_Liabilities | 23,516,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 31,230,000 |
| 9 | ResearchAndDevelopmentExpense | 20,566,000 |
| 10 | remainder_Expenses | 50,428,000 |
| 11 | remainder_Revenues | 115,450,000 |
| 12 | remainder_NetIncome | -98,000 |
| 13 | remainder_ComprehensiveNetIncome | -1,336,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 141,574,000 |
| 1 | Liabilities | 59,262,000 |
| 2 | Expenses | 102,224,000 |
| 3 | Revenues | 115,450,000 |
| 4 | StockholdersEquity | 82,312,000 |
| 5 | NetIncome | 13,128,000 |
| 6 | ComprehensiveNetIncome | 12,460,000 |
| 7 | BaseVar | 209,972,000 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.91 |
| 9 | EconomicCapitalRatio | 2.96 |
Edgar->Model Mapping
Feature Distribution
Change over Time
